IBDEI0VW ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14199,0)
 ;;=I69.964^^83^822^41
 ;;^UTILITY(U,$J,358.3,14199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14199,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
 ;;^UTILITY(U,$J,358.3,14199,1,4,0)
 ;;=4^I69.964
 ;;^UTILITY(U,$J,358.3,14199,2)
 ;;=^5133589
 ;;^UTILITY(U,$J,358.3,14200,0)
 ;;=I69.961^^83^822^42
 ;;^UTILITY(U,$J,358.3,14200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14200,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,14200,1,4,0)
 ;;=4^I69.961
 ;;^UTILITY(U,$J,358.3,14200,2)
 ;;=^5007564
 ;;^UTILITY(U,$J,358.3,14201,0)
 ;;=I69.963^^83^822^43
 ;;^UTILITY(U,$J,358.3,14201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14201,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,14201,1,4,0)
 ;;=4^I69.963
 ;;^UTILITY(U,$J,358.3,14201,2)
 ;;=^5007565
 ;;^UTILITY(U,$J,358.3,14202,0)
 ;;=G90.50^^83^822^52
 ;;^UTILITY(U,$J,358.3,14202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14202,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,14202,1,4,0)
 ;;=4^G90.50
 ;;^UTILITY(U,$J,358.3,14202,2)
 ;;=^5004163
 ;;^UTILITY(U,$J,358.3,14203,0)
 ;;=R56.9^^83^822^53
 ;;^UTILITY(U,$J,358.3,14203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14203,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,14203,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,14203,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,14204,0)
 ;;=G37.9^^83^822^54
 ;;^UTILITY(U,$J,358.3,14204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14204,1,3,0)
 ;;=3^Demyelinating Disease of Central Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,14204,1,4,0)
 ;;=4^G37.9
 ;;^UTILITY(U,$J,358.3,14204,2)
 ;;=^5003828
 ;;^UTILITY(U,$J,358.3,14205,0)
 ;;=G36.9^^83^822^55
 ;;^UTILITY(U,$J,358.3,14205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14205,1,3,0)
 ;;=3^Demyelination,Disseminated,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,14205,1,4,0)
 ;;=4^G36.9
 ;;^UTILITY(U,$J,358.3,14205,2)
 ;;=^5003820
 ;;^UTILITY(U,$J,358.3,14206,0)
 ;;=R42.^^83^822^56
 ;;^UTILITY(U,$J,358.3,14206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14206,1,3,0)
 ;;=3^Dizziness and Giddiness
 ;;^UTILITY(U,$J,358.3,14206,1,4,0)
 ;;=4^R42.
 ;;^UTILITY(U,$J,358.3,14206,2)
 ;;=^5019450
 ;;^UTILITY(U,$J,358.3,14207,0)
 ;;=R13.12^^83^822^57
 ;;^UTILITY(U,$J,358.3,14207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14207,1,3,0)
 ;;=3^Dysphagia,Oropharyngeal Phase
 ;;^UTILITY(U,$J,358.3,14207,1,4,0)
 ;;=4^R13.12
 ;;^UTILITY(U,$J,358.3,14207,2)
 ;;=^335277
 ;;^UTILITY(U,$J,358.3,14208,0)
 ;;=R13.10^^83^822^58
 ;;^UTILITY(U,$J,358.3,14208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14208,1,3,0)
 ;;=3^Dysphagia,Unspec
 ;;^UTILITY(U,$J,358.3,14208,1,4,0)
 ;;=4^R13.10
 ;;^UTILITY(U,$J,358.3,14208,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,14209,0)
 ;;=G24.9^^83^822^59
 ;;^UTILITY(U,$J,358.3,14209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14209,1,3,0)
 ;;=3^Dystonia,Unspec
 ;;^UTILITY(U,$J,358.3,14209,1,4,0)
 ;;=4^G24.9
 ;;^UTILITY(U,$J,358.3,14209,2)
 ;;=^5003790
 ;;^UTILITY(U,$J,358.3,14210,0)
 ;;=R45.86^^83^822^60
 ;;^UTILITY(U,$J,358.3,14210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14210,1,3,0)
 ;;=3^Emotional Lability
 ;;^UTILITY(U,$J,358.3,14210,1,4,0)
 ;;=4^R45.86
 ;;^UTILITY(U,$J,358.3,14210,2)
 ;;=^5019475
 ;;^UTILITY(U,$J,358.3,14211,0)
 ;;=R45.7^^83^822^61
